Paternal exposure to cyclophosphamide affects the progression of sperm chromatin decondensation and activates a DNA damage response in the prepronuclear rat zygote.
Spermatozoon decondensation in the zygote leads to the initiation of chromatin remodeling during which protamines are removed and replaced with maternal histones. We hypothesize that damage to male germ cells induced by paternal exposure to cyclophosphamide may alter the timing of spermatozoal decondensation and the pattern of chromatin remodeling in the prepronuclear rat zygote. A specific order of sperm decondensation was observed, starting at the posterior end, proceeding to the ventral sides, followed by the tip, and finally the midbody region of the sperm head nucleus; subgroups of partially decondensed type a sperm nuclei were defined as types a1, a2, a3, and a4. Based on their frequencies relative to controls, paternal exposure to cyclophosphamide accelerated the timing of spermatozoal decondensation. Two distinct patterns of chromatin remodeling were observed for totally decondensed (type b) and recondensing (type c) sperm nuclei: H4K12ac showed a homogenous staining, whereas H3S10ph displayed a ring-like staining around the sperm nucleus; the distribution of these posttranslationally modified histones was not affected by cyclophosphamide exposure. In contrast, paternal cyclophosphamide treatment increased the number of gammaH2AX foci found in decondensing sperm nuclei. Small foci were significantly increased in type a2 and a3 nuclei, whereas a significant increase in the numbers of large foci was found in type b and c nuclei. This increase in gammaH2AX foci in the decondensing male genome suggests that damage recognition and repair pathways are initiated in prepronuclear rat zygotes. Thus, exposure of male rats to chronic low doses of cyclophosphamide accelerates spermatozoal decondensation and leads to the activation of gammaH2AX recognition of DNA damage in the male genome of the prepronuclear zygote.
Grenier
Lisanne
L
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Robaire
Bernard
B
Hales
Barbara F
BF
D000818:Animals; D002467:Cell Nucleus / Q000648:ultrastructure; D002843:Chromatin / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure*; D003520:Cyclophosphamide / Q000633:toxicity*; D004249:DNA Damage / Q000187:drug effects*; D005260:Female; D005455:Fluorescent Antibody Technique; D008297:Male; D018613:Microscopy, Confocal; D018812:Paternal Exposure / Q000009:adverse effects*; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D013094:Spermatozoa / Q000648:ultrastructure*; D013997:Time Factors; D015053:Zygote / Q000737:chemistry / Q000648:ultrastructure*
D002843:Chromatin; D003520:Cyclophosphamide
J Biol Chem. 1996 Mar 29;271(13):7253-6
8631735
Nature. 2005 Oct 27;437(7063):1386-90
16251970
Biol Reprod. 1987 Feb;36(1):239-44
3567277
Dev Biol. 2006 Oct 15;298(2):458-69
16887113
Toxicol Sci. 2007 Dec;100(2):495-503
17872895
Mutat Res. 2007 Jan-Feb;635(1):53-77
17141556
Eur J Cell Biol. 2000 Dec;79(12):950-60
11152286
Biol Reprod. 1995 Jan;52(1):33-40
7711181
Proc Natl Acad Sci U S A. 1979 Jan;76(1):435-7
284360
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7865-70
15911775
Cell Cycle. 2006 Sep;5(17):1974-82
16969090
Nature. 1985 Jul 11-17;316(6024):144-6
4040213
Mol Reprod Dev. 2000 Nov;57(3):214-23
11013428
Dev Biol. 2005 Apr 1;280(1):225-36
15766761
Mol Cell Biol. 2008 Mar;28(5):1739-54
18180282
Biol Reprod. 1987 Sep;37(2):317-26
3676391
Dev Biol. 1988 Jan;125(1):181-6
3334716
Hum Reprod. 2007 May;22(5):1431-42
17303633
Biol Reprod. 1999 Mar;60(3):702-6
10026119
J Androl. 2004 May-Jun;25(3):354-62
15064312
Dev Biol. 2007 Jan 15;301(2):464-77
16989800
EMBO J. 2001 Nov 15;20(22):6383-93
11707409
DNA Repair (Amst). 2006 Aug 13;5(8):959-71
16837249
Mol Reprod Dev. 2007 Nov;74(11):1465-72
17410540
Biochim Biophys Acta. 1976 Jun 15;434(2):377-89
952894
Chromosoma. 2003 May;111(8):473-82
12743711
Cell Biol Int. 2007 Oct;31(10):1184-90
17521927
Development. 1997 Nov;124(22):4615-25
9409678
Nature. 2009 Jul 23;460(7254):473-8
19525931
Cancer Res. 2004 Apr 1;64(7):2390-6
15059890
Int J Dev Biol. 2009;53(7):1003-11
19598117
Biol Cell. 2008 Nov;100(11):633-43
18471090
EMBO J. 2000 Feb 1;19(3):379-91
10654937
Mol Reprod Dev. 2000 Jun;56(2 Suppl):319-24
10824994
J Cell Sci. 2003 Sep 15;116(Pt 18):3677-85
12917355
Best Pract Res Clin Endocrinol Metab. 2002 Jun;16(2):311-34
12064895
Biol Reprod. 2007 Aug;77(2):303-11
17475930
Biochim Biophys Acta. 1976 Apr 14;427(2):752-7
1268226
Mol Endocrinol. 1999 Jan;13(1):91-105
9892015
J Cell Biol. 1999 Sep 6;146(5):905-16
10477747
Mol Biol Cell. 2005 Oct;16(10):5013-25
16030261
J Biol Chem. 1998 Mar 6;273(10):5858-68
9488723
Mech Dev. 2005 Sep;122(9):1008-22
15922569
Curr Pharm Des. 1999 Aug;5(8):555-60
10469891
Biochemistry. 1977 Sep 6;16(18):4074-80
911755